⚠️ Rare but High Risk Safety Event
US poison center kratom calls surged more than 1,200% between 2015 and 2025, with 2025 alone recording 3,434 cases. Hospitalizations climbed in parallel, and 233 deaths were associated with kratom use during the decade.
Why It Matters
- Newer kratom products carry far higher potency than traditional leaves, with undisclosed ingredients and unpredictable mitragynine concentrations.
- 60% of polysubstance cases produced serious medical outcomes in 2025, with roughly half requiring hospitalization.
- Most affected patients are men in their 20s and 30s, but exposures are rising in the 40 to 59 age group.
- Patients often use kratom for pain, mood, or self-managed opioid withdrawal, frequently without disclosing it during clinical encounters.
What to Watch
- Ask directly about kratom use when reviewing supplements, pain regimens, or opioid withdrawal history.
- Recognize kratom as a possible contributor in unexplained hepatotoxicity, sedation, or withdrawal presentations.
- Counsel patients on interaction risks with alcohol, antidepressants, opioids, and benzodiazepines.
- Track FDA and state-level regulatory actions, since product composition and labeling remain inconsistent.
More in Poisoning/Overdose
PATIENT EDUCATION
OBESITY/WEIGHT MANAGEMENT
EXERCISE/TRAINING
LEGAL MATTERS
GUIDELINES/RECOMMENDATIONS